Literature DB >> 10399949

Risk of invasive cervical cancer among women with, or at risk for, HIV infection.

D Serraino1, P Carrieri, C Pradier, E Bidoli, M Dorrucci, E Ghetti, A Schiesari, R Zucconi, P Pezzotti, P Dellamonica, S Franceschi, G Rezza.   

Abstract

Although invasive cervical cancer (ICC) has been included among the AIDS-defining conditions since 1993, it remains controversial whether HIV infection increases the risk of developing such neoplasm. In this study, ICC risk was longitudinally investigated among 1,340 HIV-positive intravenous drug user (IDU), 811 HIV-negative IDU, and 801 HIV-positive heterosexual women. These women, aged 15-49 years, were followed up at the Italian HIV Seroconverter Study, at the San Patrignano Community (Rimini, North Italy), and in South-eastern France (the DMI-2 study). The number of observed cases of ICC was compared with the expected one, based on ICC incidence rates among women of the same age in the general population of Italy or France, and standardized incidence ratios (SIR) were computed; 9,070 person-years of observation were accumulated among HIV-positive women and 2,310 among HIV-negative ones. Ten cases of ICC were diagnosed among HIV-positive women (SIR = 12.8): ICC risk was apparently higher among HIV-positive IDU (SIR = 16.7) than among heterosexual women (SIR = 6.7). No cases of ICC were diagnosed among HIV-negative IDU women admitted to the San Patrignano Community (0.15 cases were expected). Our findings confirm previous suggestions showing an increased risk of ICC among HIV-infected women and have important implications at the individual and public health levels.

Entities:  

Mesh:

Year:  1999        PMID: 10399949     DOI: 10.1002/(sici)1097-0215(19990730)82:3<334::aid-ijc5>3.0.co;2-c

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania.

Authors:  P Mayaud; D K Gill; H A Weiss; E Uledi; L Kopwe; J Todd; G ka-Gina; H Grosskurth; R J Hayes; D C Mabey; C J Lacey
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix.

Authors:  Samantha Seresini; Massimo Origoni; Luigi Caputo; Flavia Lillo; Renato Longhi; Simone Vantini; Anna Maria Paganoni; Maria Pia Protti
Journal:  Immunology       Date:  2010-06-02       Impact factor: 7.397

3.  Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.

Authors:  Jessica A Kahn; Robert D Burk; Kathleen E Squires; Bill G Kapogiannis; Bret Rudy; Jiahong Xu; René Gonin; Nancy Liu; Carol Worrell; Craig M Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

Review 4.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

Review 5.  Cancer screening in patients infected with HIV.

Authors:  Keith Sigel; Robert Dubrow; Michael Silverberg; Kristina Crothers; Scott Braithwaite; Amy Justice
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

6.  Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.

Authors:  D B Blossom; R H Beigi; J J Farrell; W Mackay; B Qadadri; D R Brown; S Rwambuya; C J Walker; F S Kambugu; F W Abdul-Karim; C C Whalen; R A Salata
Journal:  J Med Virol       Date:  2007-06       Impact factor: 2.327

7.  Audit of gynaecological cancers Queen Elizabeth Central Hospital, Blantyre.

Authors:  Frank Taulo; Eddie Malunga; Andrew Ngwira
Journal:  Malawi Med J       Date:  2008-12       Impact factor: 0.875

8.  Long-term incidence of cervical cancer in women with human immunodeficiency virus.

Authors:  L Stewart Massad; Eric C Seaberg; D Heather Watts; Howard Minkoff; Alexandra M Levine; Donna Henry; Christine Colie; Teresa M Darragh; Nancy A Hessol
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

9.  Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated.

Authors:  S J Weissenborn; A M Funke; M Hellmich; P Mallmann; P G Fuchs; H J Pfister; U Wieland
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance.

Authors:  Matthew L Scott; Brittany L Woodby; Joseph Ulicny; Gaurav Raikhy; A Wayne Orr; William K Songock; Jason M Bodily
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.